[E.coli bacterial suspension in the treatment of hemorrhoids]

Hemorrhoidal disease is the most common proctologic disease and the search for new treatment methods, as well as an in-depth understanding of the mechanisms underlying effects of well-known agents on disease pathogenesis still remain relevant. There have been long recognized the effects of the E.coli bacterial culture suspension (BCS) as a therapeutic means eliciting decreased exudation during inflammation, wound healing, tissue regeneration, and stimulated immunity. Here, based on recent findings related to innate and adaptive immune cells, we set out to present mechanisms accounting for some effects coupled to commensal bacteria, particularly inactivated E.coli BCS, which are important for understanding pathogenesis-related action of drug Posterisan and Posterisan forte, and outline their broad application in therapy of hemorrhoids. Based on the analysis, it was concluded that such effects are mediated via multi-pronged and complementary interactions between diverse human receptors expressed in the anorectal region cells and microbial components: NOD ligands, metabolites, enzymes, heat shock proteins and nucleic acids, which lead to production of pro-inflammatory cytokines by anodermal colonocytes, innate and adaptive immune cells, neurons in the submucosal plexus covered by transitional zone epithelium, and hemorrhoid plexus endothelium. Based on current concepts, it may be plausible that E.coli BCS-derived biologically active components contained in drug Posterisan are capable of exerting both positive local and systemic effects, which extend our understanding and substantiate its use in hemorrhoidal disease. The effectiveness of using Posterisan and Posterisan forte is corroborated by their indications in real-life clinical practice, both as a conservative therapy as well as after surgical interventions.

Experimental Staphylococcus aureus Mastitis Infection Model by Teat Dipping in Bacterial Culture Suspension in Dairy Cows

Simple Summary

Udder infection by bacteria such as Staphylococcus aureus cause economic losses to dairy production. An effective vaccine is required to control S. aureus mastitis. To develop an effective vaccine, a good experimental infection model is required. Infusion of bacteria into the udder can overwhelm the host because it bypasses physical barriers and defense mechanisms in the teat canal. The objective of this study was to develop Staphylococcus aureus mastitis challenge model that mimics natural infection. Eight Holstein dairy cows within 1st to 3rd parity at early non-milking period were randomly divided into experimental (n = 5) and control (n = 3) groups. All teats of experimental cows were challenged by dipping into S. aureus culture suspension, whereas those of control cows were dipped into phosphate-buffered saline. Bacteria in the mammary secretion was determined by bacteriological culture. The antibody titer in blood was tested by enzyme-linked immunosorbent assay (ELISA). Other analyses, which include somatic cell count, rectal body temperature, inflammatory changes in mammary secretion, and gland tissues, were assessed. Results showed that three and one of five experimental cows developed subclinical and clinical mastitis, respectively. The remaining cow was infected with Staphylococcus chromogenes. In conclusion, experimental S. aureus mastitis can be induced by teat dipping in the bacterial culture.

Abstract

Mastitis is inflammation of mammary glands usually caused by bacteria such as Staphylococcus aureus. Dairy cows are susceptible to mastitis during early dry and transition periods. Effective vaccine is needed during these periods. One of the limitations to develop an effective vaccine against S. aureus is the absence of good infection model. Intramammary infusion (IMIF) with S. aureus has been used as an infection model to test vaccine efficacy. IMIF is reliable in causing mastitis, but it bypasses physical barriers, non-specific natural defenses, and immunity in the teat canal. IMIF also transfers a large number of bacteria into the intramammary area at once. The objective of this study was to develop S. aureus IMIF model that mimics natural infection. Eight Holstein dairy cows were randomly divided into two groups of experimental (n = 5) and control (n = 3) cows. All teats of experimental cows were dipped in S. aureus culture suspension, whereas that of control cows were dipped in phosphate-buffered saline. Results showed that four of five cows were infected with challenge strain by day 3 of the challenge. The remaining cow was infected with Staphylococcus chromogenes. In conclusion, an experimental S. aureus intramammary infection can be induced by teat dipping into bacterial suspension.